TOP 100 PHARMACY SITES
| |||
|
| |||
| |||
|
| |||
| Bristol-Myers’s Reliance on Three Drugs Casts Doubt on Strategy Bristol-Myers Squibb’s current strategy is to move away from mass-market drugs into more expensive drugs for rarer diseases. But more than half its sales depend on three drugs alone. nytimes.com |
The best treatment might be wrong for you Most drugs and therapies fail in half of all patients. Here's how to figure out what will work for you. msnbc.msn.com |
Merck Selling Stake in Animal Venture Merck is selling its Merial stake to clear a path for its merger with Schering-Plough, but it could create an even bigger joint venture with Sanofi after that deal wins approval. nytimes.com |
U.S. healthier in last decade? Program finds out About 10 years ago the government set some lofty health goals for the nation to reach by 2010. So how did we do? By many measures, not so hot. But the nation has made at least some progress on many other goals. Health - United States - Government - Mental Health - Disorders msnbc.msn.com |
Will overhaul slow skyrocketing health costs? Under Democrats' health plan, costs are expected to first go up, as tens of millions of previously uninsured Americans get coverage. But over time, if the plan works, health care inflation would slow. Health care - Uninsured in the United States - Democratic Party - Insurance - Health msnbc.msn.com |